Etropal AD (XBUL:ETR) FFO


XBUL:ETR Etropal AD XBUL:ETR
50 GF Score
Price €2.52
GF Value €8.56
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Etropal AD FFO?

FFO (Funds from operations) only applies to REITs.

XBUL:ETR
50GF Score
Etropal AD XBUL:ETR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Etropal AD (XBUL:ETR) Overvalued in 2026?

Based on GuruFocus' analysis, Etropal AD stock appears to be undervalued. The current stock price of €2.52 is trading 70.6% below its estimated GF Value™ of €8.56. GuruFocus considers Etropal AD to be Significantly Undervalued.

Key valuation signals for XBUL:ETR:

  • FFO:
  • GF Value™: €8.56 vs. price of €2.52 (70.6% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the XBUL:ETR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Etropal AD Business Description

Address 191 Rusky Boulevard, Etropole, Sofia, BGR, 2180
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.
50GF Score

Get the complete analysis for XBUL:ETR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52
Price
€8.56
GF Value